JPH0332495Y2 - - Google Patents
Info
- Publication number
- JPH0332495Y2 JPH0332495Y2 JP2308587U JP2308587U JPH0332495Y2 JP H0332495 Y2 JPH0332495 Y2 JP H0332495Y2 JP 2308587 U JP2308587 U JP 2308587U JP 2308587 U JP2308587 U JP 2308587U JP H0332495 Y2 JPH0332495 Y2 JP H0332495Y2
- Authority
- JP
- Japan
- Prior art keywords
- capsule
- present
- contents
- hard capsule
- cmc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000007902 hard capsule Substances 0.000 claims description 16
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 claims description 2
- 239000011575 calcium Substances 0.000 description 8
- 239000002775 capsule Substances 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 230000000694 effects Effects 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2308587U JPH0332495Y2 (enrdf_load_stackoverflow) | 1987-02-19 | 1987-02-19 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2308587U JPH0332495Y2 (enrdf_load_stackoverflow) | 1987-02-19 | 1987-02-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63130041U JPS63130041U (enrdf_load_stackoverflow) | 1988-08-25 |
| JPH0332495Y2 true JPH0332495Y2 (enrdf_load_stackoverflow) | 1991-07-10 |
Family
ID=30821077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2308587U Expired JPH0332495Y2 (enrdf_load_stackoverflow) | 1987-02-19 | 1987-02-19 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0332495Y2 (enrdf_load_stackoverflow) |
-
1987
- 1987-02-19 JP JP2308587U patent/JPH0332495Y2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63130041U (enrdf_load_stackoverflow) | 1988-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR850000625B1 (ko) | 판크레아틴 환제의 제조방법 | |
| KR960009182B1 (ko) | 제약정제, 제약과립 및 그의 제조방법 | |
| US3965256A (en) | Slow release pharmaceutical compositions | |
| KR960005140B1 (ko) | 서방성 매트릭스 제형 | |
| US2887438A (en) | Prolonged action tablets | |
| KR100202154B1 (ko) | 파라세타몰 및 돔페리돈을 함유한 필름 피복 정제 | |
| EP1622586B1 (en) | Process for preparing tannate tablet capsule or other solid dosage forms | |
| NO138683B (no) | Grunnmasse til anvendelse ved fremstilling av et farmasoeytisk preparat med langsom frigjoerelse av den aktive bestanddel | |
| JPH0751519B2 (ja) | 制御された持続性放出医薬配合物 | |
| US6291462B1 (en) | Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates | |
| JPH10511103A (ja) | エナラプリル塩の安定固形製剤及びその製造のための方法 | |
| NZ506307A (en) | Morphine sulphate microgranules, manufacturing process and pharmaceutical preparations, immediate release | |
| KR950002148B1 (ko) | 다과립형 지속성 정제 | |
| JPS5927820A (ja) | スロクチジルを含有する徐放性製品 | |
| JPH0542414B2 (enrdf_load_stackoverflow) | ||
| CA2185242C (en) | Sustained release tablet containing diclofenac-na | |
| JPH0332495Y2 (enrdf_load_stackoverflow) | ||
| JPH0196118A (ja) | ゼラチン組成物 | |
| CN108324697B (zh) | 一种含枸橼酸莫沙必利的胶囊剂及其制备方法 | |
| JPH0344052B2 (enrdf_load_stackoverflow) | ||
| US20050202080A1 (en) | In process conversion method for preparing tannate tablet, capsule or other solid dosage forms | |
| JPS59101420A (ja) | インドメタシンを含有する直腸用調製物 | |
| JPS59205375A (ja) | ピロキシカムの塩基塩の製剤化方法 | |
| WO1992004032A1 (en) | Slow release compositions | |
| JP4591726B2 (ja) | メキタジン含有内服固形製剤 |